Li Robert, Jia Zhenquan, Zhu Hong
Department of Pharmacology, Campbell University Medical School, Buies Creek, NC 27506, USA.
Department of Pharmaceutical Sciences, Campbell University College of Pharmacy and Health Sciences, Buies Creek, NC 27506, USA.
React Oxyg Species (Apex). 2019 Mar;7(20):78-85. doi: 10.20455/ros.2019.817.
Dietary supplementation with omega-3 fatty acids, also known as n-3 fatty acids, has been widely considered cardiovascular protective in the general human population. This widely acclaimed status of omega-3 fatty acids as cardiovascular protective molecules has, however, been questioned by findings from multiple rigorously designed randomized controlled trials, recently reported in the New England Journal of Medicine. Although the anti-inflammatory and other beneficial effects of omega-3 fatty acids are substantiated by research in experimental models as well as findings from observational epidemiological studies, dietary supplementation with omega-3 fatty acids at the typical dosage of 1 g daily does not appear to be an effective strategy for either primary or secondary prevention of cardiovascular disease in humans.
补充含ω-3脂肪酸(也称为n-3脂肪酸)的膳食,在一般人群中已被广泛认为具有心血管保护作用。然而,最近发表在《新英格兰医学杂志》上的多项严格设计的随机对照试验结果,对ω-3脂肪酸作为心血管保护分子这一广受赞誉的地位提出了质疑。尽管ω-3脂肪酸的抗炎和其他有益作用在实验模型研究以及观察性流行病学研究结果中得到了证实,但以每日1克的典型剂量补充ω-3脂肪酸膳食,似乎并不是人类预防心血管疾病一级或二级预防的有效策略。